Excision and Primary Anastomosis for Bulbar Urethral Strictures Improves Functional Outcomes and Quality of Life: A Prospective Analysis from a Single Centre

• Published in: BioMed research international Vol. 2019; no. 2019; pp. 1 - 9
• Main Authors: Joniau, Steven, Vander Eeckt, Kathy, Castiglione, Fabio, Floyd, Michael S., D’hulst, Pieter, Van der Aa, Frank
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01-01-2019; Hindawi; Hindawi Limited
• Subjects: Aged; Anastomosis; Anastomosis, Surgical; Clinical Study; Construction; Erectile dysfunction; Erectile Dysfunction - complications; Erectile Dysfunction - epidemiology; Erectile Dysfunction - physiopathology; Humans; Instrumentation; Lower Urinary Tract Symptoms - complications; Lower Urinary Tract Symptoms - epidemiology; Lower Urinary Tract Symptoms - physiopathology; Male; Median (statistics); Medical treatment; Middle Aged; Patient Satisfaction; Patients; Penile Erection - physiology; Prostate; Prostatic Hyperplasia - complications; Prostatic Hyperplasia - epidemiology; Prostatic Hyperplasia - physiopathology; Quality of Life; Questionnaires; Signs and symptoms; Statistical analysis; Stricture; Success; Surgeons; Surgery; Surveys and Questionnaires; Survival analysis; Urethra - physiopathology; Urethra - surgery; Urethral Stricture - epidemiology; Urethral Stricture - physiopathology; Urethral Stricture - surgery; Urinary tract; Urogenital system; Urology; United Kingdom > UK
• DOI: 10.1155/2019/7826085
• EISSN: 2314-6141
• ISSN: 2314-6133

Background. Excision and primary anastomotic (EPA) urethroplasty remains the gold standard definitive treatment for short urethral stricture disease. For patients, postoperative erectile function and quality of life are the main goals of the surgery. Patient-reported outcome measures (PROMs) are therefore of major importance. Objective. The objective of this study was to prospectively analyse functional outcomes and patient satisfaction. Design, Settings, and Participants. We prospectively evaluated 47 patients before and after EPA from August 2009 until February 2017. The first follow-up visit occurred after a median of 2.2 months (n = 47/47), with the second and third follow-ups occurring at a median of 8.5 months (n = 38/47) and 20.2 months (n = 31/47). Before surgery and at each follow-up visit, the patients received five questionnaires: the International Prostate Symptom Score (IPSS), the International Prostate Symptom Score with the Quality of Life (IPSS-QOL) score, the Urogenital Distress Inventory Short Form (UDI-6) score, the International Index of Erectile Function-5 (IIEF-5) score, and the ICIQ-Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTS-QOL) score. Surgical Procedure. Surgery was performed in all cases using the same standardized EPA technique. Outcome Measurements and Statistical Analysis. Voiding symptoms, erectile dysfunction, and quality of life were analysed using paired sample t-tests, with a multiple-testing Bonferroni correction. Any requirement for instrumentation after surgery was considered treatment failure. Results and Limitations. Patients with mild or no baseline erectile dysfunction showed significant decline in erectile function at first follow-up (mean IIEF-5 of 23.27 [standard deviation; SD: 2.60] vs. 13.91 [SD: 7.50]; p=0.002), but this had recovered completely at the third follow-up (IIEF-5: 23.25 [SD: 1.91]; p=0.659). Clinically significant improvements were noted in IPSS, IPSS-QOL-score, UDI-6-score, and ICIQ-LUTS-QOL-score at the first follow-up (p<0.0001). These improvements remained significant at the second and third follow-ups (p<0.0001) for all PROMs. Three of the patients experienced stricture recurrence. The main limitations of this study were incomplete questionnaires, loss to follow-up, and low number of patients. Conclusions. EPA results in an initial decline in erectile function, but full recovery occurred at a median of 20 months. Voiding improved significantly, and a major improvement in quality of life was noted, which persisted for up to 20 months after surgery. Patient Summary. This study showed the importance of patient-reported outcome measures in indicating the actual outcome of urethral stricture disease surgery.